Its mechanisms of action are not fully understood yet, but it has been shown that IFN-β alters cytokine production in T cells18, enhances apoptosis of TH17 cells in vitro and reduces the percentage of TH17 cells in relapsing-remitting MS (RRMS) patients19. This evidence concerns the gene IFNB1 and relapsing-remitting multiple sclerosis.